{
    "2019-04-02": [
        [
            {
                "time": "2018-09-15",
                "original_text": "Teva's Anti-CGRP Injection Ajovy Gets Approval in Europe",
                "features": {
                    "keywords": [
                        "Teva",
                        "Anti-CGRP",
                        "Ajovy",
                        "Approval",
                        "Europe"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-15",
                "original_text": "Novartis Gets Approval for Psoriasis Drug Cosentyx in China",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Psoriasis",
                        "Cosentyx",
                        "Approval",
                        "China"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-09-15",
                "original_text": "The Daily Biotech Pulse: FDA Nod For ADMA, Regulatory Setback For Apyx, Achieve Life Sciences Smoking Cessation Drug Trial",
                "features": {
                    "keywords": [
                        "FDA",
                        "ADMA",
                        "Apyx",
                        "Regulatory",
                        "Setback",
                        "Achieve",
                        "Life",
                        "Sciences",
                        "Smoking",
                        "Cessation",
                        "Drug",
                        "Trial"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}